Product
Onureg
2 clinical trials
3 indications
Indication
Acute Myeloid LeukemiaIndication
Liver InsufficiencyIndication
CancerClinical trial
A Randomized, Single Oral Dose, Open Label, Two Sequence, Two Treatment, Four Periods, Full Replicate Crossover Study to Determine the Bioequivalence of Azacitidine 300 mg Film- Coated Tablets Versus Onureg® 300 mg Film-Coated Tablets for Adult Patients With Acute Myeloid Leukaemia (AML) Under Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Phase 1, Multicenter, Open-label Study to Evaluate the Pharmacokinetics of CC-486 (Onureg®) in Subjects With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Adult Subjects With Myeloid MalignanciesStatus: Recruiting, Estimated PCD: 2025-06-01